Skip to content

13F-HR filed by ARCH Venture Management, LLC

ARCH Venture Management, LLC filed this 13F-HR for the quarter ended 2022-06-30, filed 2022-08-15, with 10 holding rows worth $820,637,000.

Accession
0001012975-22-000354
Filed
2022-08-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2022

A holdings report, 10 entries on the cover page, a total value of $820,637,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $820,637,000 with VALUE read as thousands by filing date, 13F file number 028-19358. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
KARUNA THERAPEUTICS INC48576A100COM2,912,872$368,507,000thousands by filing date
EQRX INC26886C107COM36,335,375$170,413,000thousands by filing date
DENALI THERAPEUTICS INC COM24823R105Stock5,168,749$152,116,000thousands by filing date
ERASCA INC COM29479A108Stock11,055,554$61,579,000thousands by filing date
VERVE THERAPEUTICS INC92539P101COM2,508,809$38,335,000thousands by filing date
SINGULAR GENOMICS SYSTEMS IN82933R100COM3,798,926$14,512,000thousands by filing date
REVOLUTION HEALTHCAR AQ CORP76155Y108CMN1,357,237$13,260,000thousands by filing date
METACRINE INC59101E103COM2,940,503$1,470,000thousands by filing date
RUBIUS THERAPEUTICS INC78116T103COM349,908$298,000thousands by filing date
ZYMERGEN INC98985X100COM119,205$147,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001012975-22-000354this filing2022-08-15acceptance time not in the bulk data set